KLK3 and neoplasm: According to current urological guidelines, monitoring of patients on AS is mainly based on serial prostate-specific antigen (PSA) testing and regular re-biopsies [3, 4] which might reveal histopathological tumor progression and induce definitive therapy, if needed.